Image

Study of JK07 in Patients With Chronic Heart Failure

Exploring JK07 for patients with chronic heart failure. Join our study!

Recruiting
18-85 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

Study on JK07 for Heart Failure: This study is testing a treatment called JK07 for people with chronic heart failure, which means the heart isn't pumping as well as it should over a long period. It is a Phase 2 trial, meaning it's still early in testing but has passed initial safety checks. Participants are grouped based on their heart's pumping strength, known as Left Ventricular Ejection Fraction (LVEF). Two groups exist: one with LVEF ≤ 40% and another with LVEF between 40% and 65%. Participants receive either a low dose, high dose of JK07, or a placebo (a harmless pill with no effect) at random. The chance of receiving JK07 is 2 out of 3.

  • Duration: Participants will be involved for a specific period with multiple visits needed.
  • Eligibility: Includes people aged 18-85 with certain heart conditions, excluding those with uncontrolled high blood pressure or recent heart problems.
  • Compensation: Participants may receive compensation for their time and travel.
Print
Study details
    Heart Failure With Reduced Ejection Fraction
    Heart Failure With Preserved Ejection Fraction

NCT06369298

Salubris Biotherapeutics Inc

15 February 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.